Hongyan Zhang
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical and dosimetric risk factors for radiation pneumonitis after proton therapy in lung cancer patients: a retrospective study.
Journal: Journal of thoracic disease
Published: April 26, 2025
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.
Journal: Cancer communications (London, England)
Published: April 24, 2025
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 03, 2024
HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis.
Journal: Journal of advanced research
Published: August 06, 2023
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 29, 2020
Sequential and Iterative Auto-Segmentation of High-Risk Clinical Target Volume for Radiotherapy of Nasopharyngeal Carcinoma in Planning CT Images.
Journal: Frontiers in oncology
Published: March 10, 2020
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial.
Journal: British journal of cancer
Published: December 18, 2019
Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells.
Journal: OncoTargets and therapy
Published: January 30, 2019
Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2.
Journal: OncoTargets and therapy
Published: May 13, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026